Cheap drug could save thousands from post-partum bleeding

A widely available drug could dramatically reduce the risk of death associated with bleeding after childbirth. 

A new study tested 20,000 women from around the world to see if the drug tranexamic (TXA) was beneficial. It was found that death as a result of bleeding was reduced by around 31 per cent when the drug was administered within three hours. 

The study also found that the need for emergency surgery to control post-partum bleeding was cut by 36 per cent. 

Currently, post-partum haemorrhage (PPH) results in more than 100,000 deaths across the globe, making it the main cause of maternal death. TXA, which works by stopping the breakdown of blood clots, could be key in reducing the death rate associated with PPH. 

The trial was coordinated by the London School of Hygiene and Tropical Medicine, with the results being published in the Lancet. 

No side effects were reported for mothers or babies and the positive results could mean it is used as a frontline treatment.ADNFCR-2094-ID-801835267-ADNFCR